LORAZE; LORAZEPAM AJS; LORAZEPAM SXP (Southern XP IP Pty Ltd)
Product name
LORAZE; LORAZEPAM AJS; LORAZEPAM SXP
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
249 (255 working days)
Active ingredients
lorazepam
Registration type
EOI
Indication
LORAZE; LORAZEPAM AJS; LORAZEPAM SXP (solution for injection) is now also indicated for:
- Pre-operative medication
- Premedication for prolonged investigations
- The treatment of acute anxiety states, acute agitation
- The control of status epilepticus in adults, adolescents and children. (See Section 4.2 Dose and Method of Administration)